Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial : Clinical implications and limitations
POHL, Marc A, BLUMENTHAL, Samuel, MANGILI, Ruggero, MOORE, Jack JR, REISIN, Efrain, RITZ, Eberhard, SCHEMTHANER, Guntram, SPITALEWITZ, Samuel, TINDALL, Hilary, RODBY, Roger A, LEWIS, Edmund J, CORDONNIER, Daniel J, DE ALVARO, Fernando, DEFERRARI, Giacomo, EISNER, Gilbert, ESMATJES, Enric, GILBERT, Richard E, HUNSICKER, Lawrence G, LOPES DE FARIA, Jose B
Published in Journal of the American Society of Nephrology (01.10.2005)
Published in Journal of the American Society of Nephrology (01.10.2005)
Get full text
Journal Article
Time to stop counting the tablets?
Pullar, T, Kumar, S, Tindall, H, Feely, M
Published in Clinical pharmacology and therapeutics (01.08.1989)
Published in Clinical pharmacology and therapeutics (01.08.1989)
Get more information
Journal Article